Why Aren’t More Doctors Talking About Ketamine Therapy?
This article explains why ketamine therapy is being discussed as an option for anxiety and other mood disorders. It reviews limitations of common anxiety treatments and describes how ketamine may support new thinking patterns through neuroplasticity and integration.
Course Overview
This Third Wave article explores ketamine therapy as an emerging approach for anxiety and related mood disorders. It outlines the limits of common treatments such as SSRIs and benzodiazepines, and summarizes why some clinicians are looking at ketamine as an alternative within a broader treatment plan. The piece explains ketamine’s proposed mechanism in the brain, with attention to glutamate and neuroplasticity rather than the usual serotonin model. It also describes how guided ketamine therapy and integration counseling may be used to support the therapeutic process. The content is aimed at readers interested in psychedelic-assisted therapy, especially those seeking a clear overview of ketamine’s potential role in mental health care. It is presented as a written educational article rather than a formal training program.
Who is this for?
People interested in ketamine therapy, anxiety treatment, and psychedelic mental health education.
About the Provider
Digital platform combining psychedelic education, media publishing, and multimedia content formats for consumer and practitioner audiences.
View Third Wave profileCourse Details
- PriceFree
- Lifecycle statusNo New Dates
- SkillsIntegrationPsychotherapyKetamine-Assisted TherapyCompare ketamine with standard anxiety medicationsRecognize the role of glutamate and neuroplasticity
- Categories
You will be redirected to the provider's website
Related Courses
View all coursesAdd Spravato® To Your Practice with our 8-Phases Implementation Roadmap
Spravato FastTrack is an implementation course for clinics that want to add Spravato (esketamine) services. It covers REMS certification, procurement, prior authorization, billing, documentation, and related operational steps.
Automated status check: No valid upcoming cohort date found on the source page (checked 2026-04-12).
Certificate in Psychedelic-Assisted Therapies & Research | CIISCIIS LogoCIIS Logo
A 12-month certificate in psychedelic-assisted therapies and research offered by CIIS. The program includes hybrid or online study and covers clinical competencies, research, cultural context, and ethical practice.
Curriculum
A curriculum focused on psilocybin, MDMA, and ketamine facilitation for spiritual and psychotherapeutic care. It was grounded in inclusion, reciprocity, and respect, and combined scientific, ancestral, and communal perspectives.
Automated status check: No valid upcoming cohort date found on the source page (checked 2026-04-12).